Clinical Trial Update: Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating lixisenatide pharmacokinetics (blood levels), plasma glucose effects, and safety in children and adults with Type 2 Diabetes Mellitus. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED